Insider Transactions in Q1 2025 at Mbx Biosciences, Inc. (MBX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
           
            Feb 18                          
            2025                          
           
         |           
        Carl L Gordon Director | 
           
              BUY
             
            
                Open market or private purchase
             
           | 
        Indirect | 
           
              143,170
              +6.33%
              
         |   
        
           
              $1,431,700              
              $10.84 P/Share              
                     
         | 
      
| 
           
            Feb 18                          
            2025                          
           
         |           
        Orbimed Advisors LLC Director | 
           
              BUY
             
            
                Open market or private purchase
             
           | 
        Indirect | 
           
              143,170
              +6.33%
              
         |   
        
           
              $1,431,700              
              $10.84 P/Share              
                     
         | 
      
| 
           
            Feb 14                          
            2025                          
           
         |           
        Carl L Gordon Director | 
           
              BUY
             
            
                Open market or private purchase
             
           | 
        Indirect | 
           
              47,502
              +0.74%
              
         |   
        
           
              $427,518              
              $9.88 P/Share              
                     
         | 
      
| 
           
            Feb 14                          
            2025                          
           
         |           
        Orbimed Advisors LLC Director | 
           
              BUY
             
            
                Open market or private purchase
             
           | 
        Indirect | 
           
              47,502
              +0.74%
              
         |   
        
           
              $427,518              
              $9.88 P/Share              
                     
         | 
      
| 
           
            Feb 04                          
            2025                          
           
         |           
        P. Kent Hawryluk President & CEO | 
           
              BUY
             
            
                Open market or private purchase
             
           | 
        Indirect | 
           
              50,000
              +10.03%
              
         |   
        
           
              $500,000              
              $10.69 P/Share              
                     
         |